Continuous Glucose Monitoring Market (2025-2032)
The Continuous Glucose Monitoring Market is expected to reach $31.41 billion by 2032, at a CAGR of 15% from 2025 to 2032.
- Published
- Jan 2024
- Pages
- 150
- Format
- PDF + Excel
- Report ID
- MRHC - 1041277
- Base year
- 2024
- 2032 · FORECAST
- $31.41B
- 2032
- $31.41B
- CAGR 2025–2032
- 15%
2024 baseline · 2025–2032 forecast at 15% CAGR · hover a bar for the value
Key highlights
By Component: In 2025, the Sensors Segment to Dominate the Continuous Glucose Monitoring Market
By Age Group: In 2025, the Adults Segment to Dominate the Continuous Glucose Monitoring Market
By End User: in 2025, the Home Care Settings Segment to Dominate the Continuous Glucose Monitoring Market
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | 150 |
| Format | |
| Forecast Period | 2025–2032 |
| Base Year | 2024 |
| CAGR (Value) | 15% |
| Market Size (Value) | $31.41 Billion by 2032 |
| Segments Covered | By Component · Sensors · Disposable Sensors · Implantable Sensors · Transmitters · Receivers · By Age Group · Adults · Children · By End User · Home Care Settings · Hospitals and Clinics |
| Countries Covered | North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Norway, Sweden, Denmark, Belgium, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa |
| Key Companies | DexCom, Inc. (US), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic plc (Ireland), Nemaura Medical Inc. (UK), LifeScan, Inc. (US), Senseonics Holdings, Inc. (U.S.), A. Menarini Diagnostics S.r.l (Italy), Medtrum. Technologies, Inc. (Shanghai.), B. Braun SE (Germany) |
Report overview
Segments covered: component, age group, end user. Regions: North America, Europe, Asia-Pacific, Latin America.
The growth of this market is driven by factors such as the increasing prevalence of diabetes and the number of people living a sedentary lifestyle, the benefits of CGM over conventional glucose monitoring, and the use of CGM by athletes and fitness enthusiasts. Furthermore, technological advancements in CGM devices, a shift toward personalized care and rising health awareness, and increasing accessibility for diabetes care devices in low and middle-income countries are expected to offer growth opportunities for the players operating in the continuous glucose monitoring market.
Report infographic
Market dynamics
5 factors across 3 forcesIncreasing Prevalence of Diabetes
Continuous glucose monitors help measure glucose levels in the body and send the readings to the healthcare provider through a smartphone app. Several new products have been launched in the diabetes management space in recent years; for instance, in March 2025, the U.S. Food and Drug Administration (FDA) approved DexCom, Inc.’s (U.S.) Dexcom Stelo Glucose Biosensor System. It is an over-the-counter (OTC) integrated CGM and can be used for patients aged 18 years and older. This device is suitable for people who are not on insulin and who do not have severe hypoglycemia.
Some of the risk factors of diabetes are obesity, family history, poor diet, mutations in single gene, prediabetes, sedentary lifestyle, and insulin resistance.
For instance, according to the World Health Organization (WHO), approximately 422 million people have diabetes worldwide. Continuous glucose monitoring helps patients regularly monitor their glucose levels and receive timely alerts in case of low or high glucose levels.
Benefits of CGM Over Conventional Glucose Monitoring
The rising incidence of chronic diseases enabled technological advancements in healthcare devices. One such advancement is the growing use of continuous glucose monitors. The benefits offered by CGMs over conventional devices are real-time data monitoring; provision of trend analysis to monitor glucose levels during meals, exercise, and resting periods of the patient; issue alerts in cases of extremely high or low glucose levels, enhanced diabetes management, and reduction in the use of fingerstick.
Artificial intelligence (AI) is also being integrated into CGM devices contributing to effective diabetes management. This integration leads to the optimization of treatments and helps in lifestyle management to avoid the risk of diabetes. For instance, in May 2024, January, Inc. (U.S.) launched a generative artificial intelligence (AI) supported app that can estimate and predict the glucose patterns of individuals. This app can be integrated with a CGM and can be accessed through any smartphone device to receive recommendations on calorie intake and physical activity. It also offers tips on blood glucose management and can be used by people without diabetes who are on special diets such as intermittent fasting.
Table of contents
11 chapters · 99 sections · 150 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Component | Sensors | — |
| By Age Group | Adults | Children |
| By End User | Home Care Settings | — |
By Component
- The Sensors Segment to Dominate the Continuous Glucose Monitoring Market
- The sensors segment is expected to account for the largest share of over 52.4% of the continuous glucose monitoring market.
- The rise in the preference for continuous glucose monitoring, along with frequent purchases of sensors, compared to receivers and transmitters, supports the large market share of this segment.
- Sensors require more frequent replacement compared to other components.
- Disposable sensors are replaced in 7 to 14 days after placement while implantable sensors can be replaced in 150-180 days.
By Age Group
- The Adults Segment to Dominate the Continuous Glucose Monitoring Market
- The adult segment is expected to account for a larger share of the continuous glucose monitoring market.
- This segment’s large market share can be attributed to the rise in the geriatric population with a high prevalence of diabetes and a sedentary lifestyle, leading to diseases such as obesity.
- According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in 2021, 38.4 million people of all ages had diabetes (11.6% of the population), among which 38.1 million were adults ages 18 years or older.
- However, the children segment is projected to register the highest growth rate during the forecast period.
- Children are more likely to get diagnosed with type 1 diabetes, where the body no longer produces insulin, leading to elevated glucose levels.
- For instance, according to the International Diabetes Federation (IDF) Atlas 2022, in 2022, there were 1.52 million under 20 years of age, living with type 1 diabetes globally.
- Continuous or real-time monitoring of glucose levels can help effectively manage this condition.
By End User
- The home care settings segment is expected to account for a larger share of over 82.3% of the continuous glucose monitoring market.
- The large market share of this segment is attributed to factors such as the rising prevalence of diabetes globally, increasing health awareness among people, a shift toward preventive healthcare, and easy accessibility to CGM in developed countries.
- CGM technologies provide numerous benefits in home care settings.
- There is a growing shift toward home healthcare due to the shortage of healthcare professionals and increasing consumer awareness about the monitoring of diabetic conditions through CGM.
Geographic analysis
North America
Largest shareIn 2025, North America is expected to account for the largest share of over 42.2% of the continuous glucose monitoring market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America’s significant market share can be attributed to the high accessibility to advanced technologies, the presence of prominent manufacturers in the region, significant investments in research & development, a robust reimbursement framework for continuous glucose monitoring devices, and supportive government initiatives aimed at raising awareness about diabetes. According to the Centers for Medicare and Medicaid Services (U.S.), in 2022, healthcare spending was 4.1 percent, reaching $4.5 trillion or $13,493 per person. In 2025, North America to Dominate the Continuous Glucose Monitoring Market
Asia-Pacific
Fastest growthHowever, the market in Asia-Pacific is projected to register the highest CAGR of over 17.40% during the forecast period. The growth of this regional market is driven by factors such as improving healthcare infrastructure, rising disposable income, and increasing investments by major market players. Furthermore, economic growth, as well as technological advancements are the major reasons for market growth in this region.
Competitive landscape
- February 2025
DexCom, Inc. (U.S.) launched Dexcom ONE+ in Spain, Belgium, and Poland. It is a customizable continuous glucose monitoring solution consisting of a wearable sensor, a transmitter, and a smartphone-compatible app. The device can be worn on three sites in the body. The water-resistant sensor measures blood glucose levels and sends these CGM readings to smartphones compatible with the Dexcom One application.
- December 2024
The International Diabetes Federation (IDF) partnered with FIND (Foundation for Innovative New Diagnostics) (Switzerland), a global health non-profit organization, to advance capacity building in CGM technology for healthcare providers and people living with diabetes. This collaboration is a part of the project ACCEDE (ACcess to CGMs for Equity in DiabEtes management), which aims to enhance diabetes management and the use of CGMs in low and middle-income countries, mainly Kenya and South Africa.
- DexCom, Inc. (US)
- Abbott Laboratories (US)
- F. Hoffmann-La Roche Ltd · Switzerland
- Medtronic PLC · Ireland
- Nemaura Medical Inc. (UK)
- LifeScan, Inc. (US)
- Senseonics Holdings, Inc. · Maryland
- A. Menarini Diagnostics S.r.l · Italy
- Medtrum Technologies, Inc. (Shanghai.)
- B. Braun SE · Germany
Frequently asked questions
This market study covers the market sizes and forecasts of the continuous glucose monitoring market based on component, age group, end user, and geography. This market study also provides the value analysis of various segments and sub-segments of the continuous glucose monitoring market at the regional and country levels.
Cite this report
Meticulous Research. (2024). Continuous Glucose Monitoring Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 1041277). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/continuous-glucose-monitoring-market-5960